Home > Boards > US OTC > Delisted >

Nanogen Inc. (fka NGEN)

RSS Feed
Add Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 5/7/2014 12:18:50 PM - Followers: 11 - Board type: Free - Posts Today: 0


Nanogen, Inc.


New url http://www.epochbio.com/ ©2011 Nanogen, Inc. — All rights reserved. (Old url http://www.nanogen.com/)

 PARIS, FRANCE – June 25, 2009 – The ELITech Group, a French privately held group of companies and worldwide manufacturer and distributor of in vitro diagnostic equipment and reagents, announces that an order has been entered in the Bankruptcy Court of the District of Delaware approving its acquisition of substantially all of the assets of Nanogen, Inc. (Pink Sheets: NGEN), Epoch Biosciences, Inc., and Nanotronics, Inc., including Nanogen Advanced Diagnostics S.r.l., a wholly-owned subsidiary of Nanogen, Inc., under the terms of an asset purchase agreement dated May 13, 2009. This court order now clears the way for ELITech to complete the acquisition of Nanogen and, subject to customary closing conditions, the parties expect to close the transaction on or about June 30, 2009.



Nanogen Advanced Diagnostics

Based in Italy, Nanogen Advanced Diagnostics (NAD) is a wholly owned subsidiary of Elitech Group and the European base of operations. NAD and has been active as a supplier of advanced diagnostic products since the early 1990s when it began commercializing molecular diagnostic reagents.



 The ELITech Group

 The ELITech Group (http://www.elitechgroup.com) is a high-growth, profitable in vitro diagnostics company with global sales and distribution capabilities in over 100 countries. The group offers clinical chemistry, microbiology, immunology and electrophoresis products and operates globally, leveraging products from its own clinical chemistry and microbiology equipment and reagents facilities in Europe and North America, as well as complementary third-party products. In May 2007, the ELITech Group acquired Wescor, Inc., Utah (http://www.wescor.com) to broaden its biomedical product platform and to provide a base for business expansion in North America. In October 2007, the ELITech Group acquired Vital Scientific B.V. in the Netherlands to allow the group to offer a complete clinical chemistry solution. The ELITech Group plans to actively pursue its external growth strategy in the coming years.

For additional information, please contact Pierre Debiais :
(tel. +33 (0) 1 41 45 07 10).


SYN Biotechnology

SYN Biotechnology; is the ONLY authorized vendor all across the country among the distributor of Applied Biosystems, Nanogen Advanced Diagnostic, Prionics AG, Molgentix products.



2010/01/28 - The ELITech Group announces the sale of microarray assets to Gamida for Life

PARIS, FRANCE – January 26, 2010 – The ELITech Group, a privately held group of companies and worldwide manufacturer and distributor of in vitro diagnostic equipment and reagents, announces that its Epoch Bioscience division of Wescor, Inc has sold the intellectual property and tangible assets associated with its electronic microarray technology, previously acquired as part of the ELITech Nanogen asset purchase, to the Gamida For Life Group. The microarray technology includes all properties associated with the so-called NC400 electronic microarray product line."Our NC400 technology is an important nucleic acid profiling platform with particular applications in single nucleotide polymorphism applications. The microarray technology will be developed and applied within the Gamida for Life Group principally by Gamidor Diagnostics and Savyon Diagnostics, who are strong diagnostic solution providers with a growing molecular diagnostics presence. The Gamida for Life Group has developed a variety of focused applications for the NC400 and we believe that our divestiture of these former Nanogen assets to it will allow the full and appropriate realization of the potential for this cutting-edge technology.
The asset sale allows ELITech to remain focused on our core strengths and gives us the ability to enhance our presence in molecular diagnostics through our attention on real-time PCR relationship", said Pierre Debiais, the ELITech Group's President and founder.

The ELITech Group has become a major player in the international medical market. The Elitech Group has brought together IVD specialty companies to provide the best offering of innovative, unique and also routine products to laboratories operating closer to the patient. It comprises:
- Vital Scientific and Seppim which manufacture a full range of clinical chemistry analyzers and reagents;
- ELITech Microbio (former International Microbio) which manufactures microbiology kits;
- Wescor which manufactures unique laboratory instruments such as strainers and sweat test devices;
- inoDiag which manufactures a unique multiplex serology device;
- Nanogen which manufactures leading edge technology molecular biology kits;
- SERFIB which develops and manufactures well established microbiology and immunology kits such as reagents for the detection of parasites and rheumatoid factors. Through direct sales in Europe and North America and distribution capabilities in over 100 countries, the ELITech Group offers clinical chemistry, microbiology, immunology and molecular biology products from its own facilities as well as complementary third-party products see www.elitechgroup.com.

Gamida for Life is a privately-owned international group of companies dedicated to the healthcare field. The principal holding company is Gamida for Life BV of the Hague, the Netherlands. Through subsidiaries in Bulgaria, France, Israel, Turkey, the United Kingdom and elsewhere and distribution networks worldwide, the Group markets, sells and services diagnostic systems, medical rquipment and devices and products for scientific research sourced both from its own development and manufacture and from leading international suppliers.  



Gamida for Life site

Welcome to the Gamida for Life site.

We are an international group of companies operating in the healthcare and related fields.
With our administrative base in the Netherlands, we presently operate through member companies in France, Israel, Bulgaria, Turkey and the United Kingdom and a worldwide network of distributors and other collaborators.
The group's purpose is to generate and implement ideas for both preventive and contingency actions that will improve people's quality of life and thus assist their self-fulfillment. This purpose is realized through close relationships with customers, suppliers and researchers as well as the group's own manufacturing, quality assurance, distribution and service facilities. 
Gamida for Life achieves capital gain by initiating start-up ventures for which the funds accruing from its operating companies provide the necessary seed investment.
For more information please contact us at: info@gamida-for-life.co.il


The company forms part of the international Gamida for Life Group, which is privately-owned and dedicated to the healthcare field. The principal holding company is Gamida for Life BV of Rotterdam, the Netherlands.

In France, Gamida SA and its subsidiaries are engaged in the development and production of medical equipment and devices for sale in both the home market and abroad, as well as in the distribution in France of products from international suppliers.

In Israel, the Group's interests are more diverse. Medical equipment and devices, as well as pharmaceutical products, are distributed by Gamida-MedEquip Ltd, which also offers a specialized supply service to industrial critical environments. Danyel Biotech Ltd. distributes biotechnological products to research laboratories. Through GamidaGen Ltd. and GamidaSense Diagnostics Ltd, the latter being a joint venture with the principal scientists involved, the Group is engaged in the research, development, production and sale of diagnostic products. Volcano Ltd. has recently been established to develop and exploit technology in the same field. Gamida for Life BV is also the founding shareholder of Gamida Cell Ltd, which is developing new techniques for cell and gene therapy.

Healthcare researches, develops and produces in vitro diagnostic tests for sale worldwide under the SAVYON name. Healthcare has acquired two of the Group's major Israeli operations: Gamidor Ltd, which distributes product lines for research and industrial laboratories, and Gamidor Diagnostics, which supplies systems, instruments and reagents to clinical laboratories. It has also promoted a number of start-up research and development ventures, such as Glycodata Ltd. in the field of glycobiology.

Elsewhere, the Group's interests include distribution houses under the Gamidor name in Bulgaria and Turkey.

In addition, through Gamida for Life (Israel) Ltd, the Group is engaged in the development and dissemination of a range of educational tools for businesses, institutions and individuals in both Israel and the Palestinian autonomy.

Whenever needed, the Company is able to draw upon the knowledge and skills of colleagues throughout the Group, with whom close contact is maintained.

Gamidor Technical Services Ltd
Biomedical Services & Supplies
6 Hawksworth, Southmead Park
Didcot, Oxfordshire, OX11 7HR
United Kingdom

Tel: +44 (0)845 054 0616
Fax: +44 (0)845 054 0626
Email: service@gamidor.co.uk



02/05/2010 (16:30 ET) NGEN: Filed New Form SC 13G/A, Beneficial Ownership Disclosure - Edgar
10/06/2009 (07:30 ET) Xenomics Appoints Bruce A. Huebner as Chief Executive Officer and Board Member - Business Wire
08/14/2009 (13:13 ET) NGEN: Filed New Form 8-K, Material Event Disclosure - Edgar
07/13/2009 (15:51 ET) Nanogen Finalizes Asset Sale - Close-Up Media
07/13/2009 (13:40 ET) NGEN: Volume Spike; 40% > 20-adsv, Stock -8.00% - Knobias
07/13/2009 (10:01 ET) NGEN: New 52-Wk Low @ $0.022 dn 12% - Knobias
07/10/2009 (11:05 ET) NGEN: New 52-Wk Low @ $0.025 dn 16.67% - Knobias
07/09/2009 (10:15 ET) NGEN: Volume Spike; 9% > 20-adsv, Stock -18.42% - Knobias
07/09/2009 (10:15 ET) NGEN: New 52-Wk Low @ $0.031 dn 18.42% - Knobias
07/09/2009 (06:02 ET) NGEN: Filed New Form 8-K, Material Event Disclosure - Edgar
07/08/2009 (17:47 ET) Nanogen Completes Asset Sale - Business Wire
07/02/2009 (12:15 ET) NGEN: Volume Spike; 36% > 20-adsv, Stock +1.22% - Knobias
07/01/2009 (10:55 ET) NGEN: Volume Spike; 85% > 20-adsv, Stock -2.22% - Knobias
05/15/2009 (17:30 ET) NGEN: Filed New Form 8-K, Material Event Disclosure - Edgar
05/15/2009 (10:30 ET) NGEN: Volume Spike; 13% > 20-adsv, Stock +17.07% - Knobias
05/14/2009 (11:06 ET) SmarTrend(R) News Watch: Nanogen Files For Chapter 11 - Comtex SmarTrend Morning Call
05/14/2009 (09:00 ET) Nanogen Enters Asset Purchase Agreement with Elitech - Business Wire
03/31/2009 (21:06 ET) Nanogen, Inc. (NGEN.PK) Corporate Event Announcement Notice - Wall Street Horizon
03/30/2009 (21:01 ET) Nanogen, Inc. (NGEN.PK) Corporate Event Announcement Notice - Wall Street Horizon
03/30/2009 (17:08 ET) NGEN: Filed New Form 8-K, Material Event Disclosure - Edgar
03/27/2009 (06:11 ET) NGEN: Filed New Form 8-K, Material Event Disclosure - Edgar



Posting Rules for the NGEN board!

All posters will be subject to the IHub TOU agreement.
Any messages that violate the User Agreement or detracts from the civility of the board will be removed.

#232   NGEN revoked: Renee 05/07/14 12:18:50 PM
#231   No. Never owned NGEN. Just noticed DTCC clearance scon 04/15/14 11:15:36 AM
#230   Hey man, are you still holding here? I FirstRodeo 04/15/14 02:54:41 AM
#229   NGEN reinstated by SEC according to DTCC website. scon 01/22/14 03:04:42 PM
#228   NGEN SEC Suspension: Renee 01/07/14 09:36:44 AM
#227   look up Roy London 07/29/13 10:12:51 PM
#226   NGEN .007 SuperC 04/09/13 06:25:12 PM
#225   NGEN .009 SuperC 03/25/13 09:33:39 AM
#224   NGEN .0087 .01_HOD, now back up. SuperC 03/22/13 12:31:58 PM
#223   NGEN .0078 continues... SuperC 03/21/13 11:49:26 AM
#222   NGEN .0065 not much else to say: http://stockcharts.com/c-sc/sc?s=NGEN&p= SuperC 03/20/13 08:29:56 PM
#221   NGEN skull-bones.. I love these :) http://www.otcmarkets.com/stock/NGEN/company- SuperC 03/19/13 03:21:30 PM
#220   NGEN historical: http://www.profitspi.com/stock/view.aspx?v=price-and-chart&p=17 SuperC 03/19/13 03:20:05 PM
#219   NGEN .006 now, further update: 3_Month A/D SuperC 03/19/13 03:19:33 PM
#218   NGEN .005 update: http://investorshub.advfn.com/boards/read_msg.aspx?message_id= SuperC 03/14/13 04:47:34 PM
#217   LOL...I'm out too!!! elbowroom 08/21/12 10:18:39 AM
#216   Wow my sell went through, and its up Abag 08/21/12 10:14:26 AM
#215   Good luck...keep on watch list. I seen elbowroom 08/09/12 11:06:19 AM
#214   Well looks like a bust, im out of Abag 08/09/12 10:40:35 AM
#213   Sellers are gone!!! Great volume for 10:45am!! elbowroom 08/07/12 10:45:51 AM
#212   yup!! elbowroom 08/07/12 10:02:26 AM
#211   This is going to the .10-.20 range..... Abag 08/07/12 09:58:12 AM
#210   We blew through the vol. and moving averages!!!! elbowroom 08/07/12 09:55:37 AM
#209   Per last 13g Seth Hoogasian, is president of Abag 08/07/12 09:50:00 AM
#208   Common sense would suggest, that something is happening elbowroom 08/07/12 09:47:34 AM
#207   Ask is at .02 for a reason imo! elbowroom 08/07/12 09:42:15 AM
#206   We break .02 cents today!!!! elbowroom 08/07/12 07:16:46 AM
#205   Cool...Post all your findings...I will do the same!!! elbowroom 08/06/12 04:50:37 PM
#204   TMO Abag 08/06/12 04:40:55 PM
#203   Do you know what company? elbowroom 08/06/12 04:39:25 PM
#202   NGEN is connected to a $56.00 a share Abag 08/06/12 04:34:12 PM
#201   Good be....its something good!!!! elbowroom 08/06/12 03:53:46 PM
#200   R/M is what it looks like.... Abag 08/06/12 03:51:28 PM
#199   LUNCH TIME, WE WILL RALLY!!! elbowroom 08/06/12 11:30:19 AM
#198   Me Too!!! elbowroom 08/06/12 11:13:44 AM
#197   Its official, the most shares ever traded on Abag 08/06/12 10:49:45 AM
#196   Hello!!! elbowroom 08/06/12 09:48:25 AM
#195   I've been waiting for this day.. excelllent entry Seshet 03/01/12 03:34:30 AM
#194   NGEN up on light volume Chasing Stars 10/03/11 10:24:23 AM
#193   If NGEN is trading, does it matter who nranger 08/17/11 06:57:26 AM
#192   Can you tell me why the volume of Drax Tracks 08/16/11 12:51:28 PM
#191   Triforce, why do you post all this nonsense? Unstoppable_1 05/29/11 12:20:27 AM
#190   Visit us at CVS Triforce 05/06/11 12:05:03 PM
#189   must be an issue with my firm this basssque 03/03/11 11:22:14 AM
#188   Level II 10:50 (all normal) :-) Triforce 03/03/11 10:51:08 AM
#187   my brokerage account is showing no bid and basssque 03/03/11 10:42:46 AM
#186   Global Cardiovascular Disease Diagnostics Market to Reach US$12.4 Triforce 02/25/11 05:14:44 AM
#185   marked! bradakus 02/22/11 11:01:56 PM
#184   Mr. Ludvigson is also a Director of China locksflooring 01/24/11 03:56:45 PM
#183   ©2011 Nanogen, Inc. — All rights reserved. Triforce 01/11/11 04:36:23 AM